Showing 1,061 - 1,080 results of 6,841 for search '"Japan"', query time: 0.09s Refine Results
  1. 1061
  2. 1062
  3. 1063
  4. 1064
  5. 1065

    Pediatric Patient and Parental Anxiety and Impressions Related to Initial Gastrointestinal Endoscopy: A Japanese Multicenter Questionnaire Study by Shin-ichiro Hagiwara, Yoshiko Nakayama, Manabu Tagawa, Katsuhiro Arai, Takashi Ishige, Takatsugu Murakoshi, Hiroko Sekine, Daiki Abukawa, Hiroyuki Yamada, Mikihiro Inoue, Takeshi Saito, Takahiro Kudo, Yoshitaka Seki

    Published 2015-01-01
    “…Patients aged <19 years undergoing initial gastrointestinal (GI) endoscopy and their parents were invited to complete a self-administered questionnaire related to endoscopy in 13 institutions in Japan. Results. The subjects were 128 children, aged 1 month to 17 years. …”
    Get full text
    Article
  6. 1066
  7. 1067

    Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin by Hirokazu Suii, Itaru Ozeki, Ryoji Tatsumi, Masakatsu Yamaguchi, Mutsuumi Kimura, Tomohiro Arakawa, Tomoaki Nakajima, Yasuaki Kuwata, Takumi Ohmura, Shuhei Hige, Yoshiyasu Karino, Joji Toyota

    Published 2017-01-01
    “…In 2014, sofosbuvir (SOF) was approved for the treatment of chronic HCV genotype 2 in Japan. SOF/RBV therapy is more effective against genotype 2 than IFN/RBV therapy. …”
    Get full text
    Article
  8. 1068
  9. 1069
  10. 1070
  11. 1071
  12. 1072

    Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer by Seiichi Kato, Manabu Takai, Koji Iinuma, Shota Fujimoto, Masahiro Nakano, Takashi Ishida, Masahiro Uno, Masayoshi Tamaki, Mitsuhiro Taniguchi, Hisao Komeda, Yoshito Takahashi, Takuya Koie

    Published 2021-01-01
    “…We retrospectively included 46 mCRPC patients who received DOC followed by CBZ at quaternary hospitals in Japan between February 2015 and March 2019. Participants received intravenous DOC (40–75 mg/m2) every 3–4 weeks; CBZ (15–25 mg/m2) was administered every 3–4 weeks. …”
    Get full text
    Article
  13. 1073
  14. 1074
  15. 1075
  16. 1076
  17. 1077

    A Principal Component Analysis of Metabolome and Cognitive Decline Among Japanese Older Adults: Cross-sectional Analysis Using Tohoku Medical Megabank Cohort Study Data by Sakura Kiuchi, Kumi Nakaya, Upul Cooray, Kenji Takeuchi, Ikuko N. Motoike, Naoki Nakaya, Yasuyuki Taki, Seizo Koshiba, Shunji Mugikura, Ken Osaka, Atsushi Hozawa

    Published 2025-01-01
    “…Methods: This cross-sectional study used data from a cohort survey of community-dwelling older adults aged ≥60 years living in Miyagi, Japan, conducted by Tohoku Medical Megabank Organization between 2013 and 2016. …”
    Get full text
    Article
  18. 1078
  19. 1079
  20. 1080